Lietuvos sveikatos mokslų universitetas About Medicina Editorial Office Instructions to Authors Links Online Submission Old site

Medicina issued since 1920

Volume 50, Issue 4, 2014

Browse by category:

  • Abstracts
  • Articles
  • Clinical case reports
  • Guidelines
  • Reviews
  • Previous Issues

Never miss an issue!

Subscribe
Articles

Medicina (Kaunas) 2014; 50 (4): 222-9
DOI: 10.1016/j.medici.2014.09.005

The significance of reduced glutathione and glutathione S-transferase during chemoradiotherapy of locally advanced cervical cancer.

Lina Daukantienė 1
Birutė Kazbarienė 1
Konstantinas Povilas Valuckas 1
Janina Didžiapetrienė 1
Aurelija Krikštaponienė 1
Eduardas Aleknavičius 2,3
1 National Cancer Institute, Vilnius, Lithuania
2 Radiotherapy and Drug Therapy Centre, National Cancer Institute, Vilnius, Lithuania
3 Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Keywords
Cervical cancer
Chemoradiation
Glutathione S-transferase
Reduced glutathione

To determine changes in reduced glutathione (GSH) and glutathione S-transferase (GST) during neoadjuvant chemotherapy followed by concurrent chemoradiation for patients with stage IIB-IIIB cervical cancer, and to evaluate their significance to the efficacy of the treatment. According to the prospective phase II study protocol, 36 patients with stage IIB-IIIB cervical cancer were enrolled. A short course of intensive weekly neoadjuvant cisplatin and gemcitabine chemotherapy followed by concurrent weekly cisplatin and gemcitabine-based chemoradiation was administered. Blood samples for GSH, GST analysis were collected and analyzed before the start of the treatment, after neoadjuvant chemotherapy, and after the end of the chemoradiation. A statistically significant increase in the concentration of GSH after neoadjuvant chemotherapy was identified. After chemoradiation, values of this rate significantly decreased in contrast with GSH concentration after neoadjuvant chemotherapy in cases of stage IIB, regional metastases negative patients group, patients with a positive response to treatment, and patients who had no progression of the disease during the first 2 years after treatment. Statistically significant changes in GST during the treatment were not identified; the GST concentration after chemoradiation showed a statistically significant difference in GST concentrations in terms of the progression of the disease and disease without progression. The results suggest that changes in the concentration of GSH during the treatment of locally advanced cervical cancer might be important for the prediction of the efficacy of the treatment. Statistically significant changes in GST concentration levels during the treatment were not observed.

Correspondence to L. Daukantienė National Cancer Institute, Vilnius, Lithuania. Electronic address: lina.daukantiene@vuoi.lt

Received 29 April 2014, accepted 18 September 2014, available online 1 October 2014.

Download Full PDF

Also in this category

Abstracts of the International Scientific Conference on Medicine organized within the frame of the 82nd International Scientific Conference of the University of Latvia Riga, Latvia

Abstracts accepted for the Scientific and Practical Conference “MODERN MEDICINE: a NEW APPROACH and RELEVANT RESEARCH” among the medical educational organizations of Kazakhstan, FSU and beyond, confined to the World Osteoporosis Day (WOD) conducted within the framework of NTP AR09563004 “Features of metabolism and the state of bone mineral density in adolescent girls with primary dysmenorrhea”

Also from this Author

Reviews

E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.

(pages: 1-9)
Kristina Bielskienė
Lida Bagdonienė
Julija Mozūraitienė
et al.
Download

Articles

Postmastectomy internal mammary nodal irradiation: A long-term outcome.

(pages: 230-6)
Eduardas Aleknavičius
Vydmantas Atkočius
Irena Kuzmickienė
et al.
Download

Medicina is a peer-reviewed monthly scientific journal of Lithuanian Medical Association, Lithuanian University of Health Sciences and Vilnius University

eISSN 1648-9144

ISSN 1010-660X

2021 © Lithuanian University of Health Sciences, A. Mickevičiaus g. 9, LT 44307 Kaunas.

Tel. +370 37 327229, Faks. +370 37 220733, E-mail: medicina.editor (at) lsmuni.lt

Concept & code – BÜRO